The Role of Oxidized LDL in Atherogenesis: Immunological Response and Anti‐phospholipid Antibodies
Data up to Jan 2025
Total Citations Per Year
Abstract
References (27)
Beyond Cholesterol
1989 • 6,533 citations
Role of oxidized low density lipoprotein in atherogenesis.
1991 • 2,691 citations
Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition
1979 • 2,458 citations
Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.
1989 • 1,914 citations
Atherosclerosis: Basic Mechanisms
1995 • 1,697 citations
Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.
1984 • 1,631 citations
Low density lipoprotein undergoes oxidative modification in vivo.
1989 • 1,537 citations
The oxidation hypothesis of atherosclerosis
1994 • 1,418 citations
Autoantibody against oxidised LDL and progression of carotid atherosclerosis
1992 • 1,332 citations
CD36 is a receptor for oxidized low density lipoprotein
1993 • 1,271 citations
Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins.
1981 • 1,037 citations
Expression cloning of SR-BI, a CD36-related class B scavenger receptor.
1994 • 818 citations
Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions.
1991 • 669 citations
Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.
1996 • 557 citations
Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture.
1984 • 547 citations
LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture
1979 • 512 citations
Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.
1995 • 412 citations
Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein.
1996 • 354 citations
Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells.
1995 • 311 citations
The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68.
1995 • 310 citations
Anti-Cardiolipin Antibodies and Risk of Myocardial Infarction in a Prospective Cohort of Middle-Aged Men
1995 • 306 citations
Role of Oxidized LDL and Antioxidants in Atherosclerosis
1995 • 164 citations
Recognition of oxidatively damaged erythrocytes by a macrophage receptor with specificity for oxidized low density lipoprotein.
1994 • 151 citations
Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein
1994 • 142 citations
Oxidized lipoproteins, altered cell function and atherosclerosis
1994 • 138 citations
Immune Mechanisms in Atherogenesis
1994 • 49 citations
Immune Functions of the Vessel Wall
2024 • 10 citations